Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic factors in bladder carcinoma.

H Wolf1

  • 1Department of Urology, Skejby Sygehus, University of Aarhus, Denmark.

Scandinavian Journal of Urology and Nephrology. Supplementum
|January 1, 1991
PubMed
Summary

Understanding bladder tumors improves treatment and prognosis by analyzing host and tumor factors. Further research into biological markers is needed for more accurate predictions in bladder cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Oral hairy leukoplakia in human immunodeficiency virus positive patients: clinical and etiopathogenic aspects].

Acta otorrinolaringologica espanola·1992
Same author

Reactivities of HIV-1 gag-derived peptides with antibodies of HIV-1-infected and uninfected humans.

AIDS research and human retroviruses·1992
Same author

Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.

European journal of immunology·1992
Same author

Localization and identification of T-(Gal beta 1-3GalNAc alpha 1-O-R) and T-like antigens in experimental rat bladder cancer.

The Journal of urology·1992
Same author

Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.

Cancer research·1992
Same author

Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancer.

International journal of cancer·1992

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • Basic and clinical research has advanced the understanding of bladder tumor disease.
  • Characterizing host and tumor factors aids clinicians in selecting treatments, follow-up strategies, and predicting prognosis.

Purpose of the Study:

  • To identify key variables for determining bladder tumor prognosis at presentation.
  • To explore the potential of various biological markers for improved bladder cancer prediction.

Main Methods:

  • Evaluation of tumor factors (T-category, grade, size, invasion, etc.) and host factors (immune status, age, performance status, etc.).
  • Assessment of numerous biological markers including cytogenetic, cytomorphometric, immunohistochemical (e.g., ABH, T-antigen, CEA), and ultrastructural characteristics.
  • Analysis of proliferative indices and morphometric data.

Main Results:

  • Several tumor and host factors are crucial for predicting bladder cancer course.
  • Various biological markers show potential clinical value but are not yet in routine use.
  • Current predictors are insufficient for all individual bladder tumor cases.

Conclusions:

  • Accurate assessment of tumor and host factors is vital for bladder cancer management.
  • Continued research into biological markers is necessary to fully disclose tumor potential and host interaction.
  • The goal is to achieve more precise prediction of individual bladder tumor behavior.

Related Experiment Videos